A Phase III study of M121101 in patients with pincer nail

A Phase III, Randomized, Placebo-controlled, Investigator-blinded, Parallel, Multi-Center Study of M121101 in patients with pincer nail

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031200264

Enrollment

Registered

2020-12-24

Start date

2020-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pincer nail

Interventions

single application

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pincer nail patients

Exclusion criteria

Exclusion criteria: (1)Patients with complications of any of ingrown nail, onychomycosis, nail psoriasis, onychogryphosis, and pachyonychia at the application site (2)Patients with a nail plate thickness of less than 1 mm at the application site

Design outcomes

Primary

Measure	Time frame
Distal nail width narrowing rate	—

Secondary

Measure	Time frame
Adverse events	—

Contacts

Public ContactClinical Infomation

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026